NEW YORK (GenomeWeb News) – The University of Groningen in the Netherlands plans to invest €2 million ($3.1 million) over the next five years in its newly created synthetic biology research center, the university said in a statement Thursday.
 
The Center for Synthetic Biology will have three main areas of focus: "cell factories" for producing pharmaceuticals, antibiotics, and proteins; systems for controlled drug delivery and new diagnostics; and biosensors and biochips based on biological components.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.